Core Insights - Tumor metastasis is the leading cause of death in cancer patients, and a new technology platform called CLIM-TIME has been developed to reveal the basic rules of how genetic mutations in tumors modify the microenvironment, leading to immune therapy resistance [1] Group 1: Research Findings - The research team analyzed 391 common tumor suppressor genes and categorized the resulting metastatic microenvironments into seven types, focusing on one specific type that is rich in collagen [1] - The dense collagen-rich microenvironment acts like a web created by tumor cells, which not only provides structural support but also traps more immune cells, forming a barrier that hinders T cells from effectively attacking the tumor [1] Group 2: Methodology and Implications - The study established a causal link between intrinsic genetic disturbances in tumors, microenvironment structure, and the effectiveness of immune therapy on a high-throughput scale [1] - While the research is based on animal models, the clinical scenarios are more complex, indicating the need for further evaluations of safety and efficacy [1]

Core Insights - The study reveals that glucose metabolism is a critical energy source for tumor proliferation, and targeting glucose metabolism through low-carbohydrate diets is a promising strategy to inhibit tumor growth [2][9] - However, extreme carbohydrate restriction may suppress tumor growth while simultaneously promoting lung metastasis, indicating the need for careful evaluation of metabolic intervention strategies [3][9] Mechanism of Action - Glucose deprivation induces endoplasmic reticulum (ER) stress in tumor cells, activating HRD1 to catalyze the ubiquitination of TRAIL at the K63 site, which is then packaged into exosomes [4] - These exosomes release TRAIL in the lungs, polarizing PVR⁺ macrophages and depleting lung NK cells, thus creating a favorable immune microenvironment for tumor colonization [4] Clinical Implications - The research confirms that low glucose metabolism is associated with higher recurrence rates within two years post-surgery across 15 cancer types [5] - Plasma exosomal TRAIL levels serve as an effective biomarker for predicting lung metastasis after liver cancer surgery, outperforming traditional biomarkers like alpha-fetoprotein (AFP) [6] Key Findings - Low-carbohydrate diets or impaired glucose metabolism can promote lung metastasis [7] - Glucose deprivation creates a pre-metastatic microenvironment dominated by lung macrophages [7] - Exosomal TRAIL leads to the polarization of PVR⁺ macrophages, resulting in the depletion of lung NK cells [7] - Plasma exosomal TRAIL levels can accurately predict early postoperative lung metastasis [7] Research Value - The study systematically elucidates how glucose restriction reshapes distal immune environments and promotes tumor metastasis through an exosome-immune regulatory axis, highlighting the TIGIT pathway as a potential target for combined interventions [9]